Schulich Heart Centre, Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Am Heart J. 2018 May;199:144-149. doi: 10.1016/j.ahj.2018.02.010. Epub 2018 Feb 13.
Although the burden of aortic stenosis (AS) on our health care system is expected to rise, little is known regarding its epidemiology at the population level. Our primary objective was to evaluate trends in AS hospitalization, treatment and outcomes.
We performed a population-based observational study including 37,970 patients newly hospitalized with AS from 2004 and 2013 in Ontario, Canada. We calculated age- and sex-standardized rate of AS hospitalization through direct standardization. The independent association between year of the hospitalization, and 30-day and 1-year mortality rate was evaluated using logistic regression models to account for temporal changes in patient characteristics.
The overall age- and sex-standardized AS hospitalization rate increased slightly from 36 per 100,000 in 2004 to 39 per 100,000 in 2013. A substantial increase was seen in patients ≥85years, where hospitalization rates increased 29% from 400 to 516 per 100,000 from 2004 to 2013 (P<.001). In this study period, 36.2% of patients received aortic valve interventions within 30days of hospitalization. Among treated patients, an improving mortality trend was observed in which the adjusted odds ratio (OR) was significantly lower in 2013 as compared to 2004 (OR 0.55 for 30-day mortality, 0.74 for 1-year morality). In contrast, no significant temporal change in mortality was seen among patients without aortic valve intervention.
AS hospitalizations in the elderly increased significantly beyond that was expected from population growth. Many AS patients did not receive aortic valve intervention after hospitalization. Mortality among the treated patients improved significantly over time.
尽管主动脉瓣狭窄(AS)对我们医疗保健系统的负担预计会增加,但在人群层面上,其流行病学情况知之甚少。我们的主要目标是评估 AS 住院治疗、治疗方法和结果的趋势。
我们进行了一项基于人群的观察性研究,纳入了 2004 年至 2013 年期间在加拿大安大略省新诊断为 AS 并住院的 37970 名患者。我们通过直接标准化计算了 AS 住院率的年龄和性别标准化率。使用逻辑回归模型评估了住院年份与 30 天和 1 年死亡率之间的独立关联,以考虑患者特征的时间变化。
总体而言,年龄和性别标准化的 AS 住院率从 2004 年的每 10 万人 36 例略微增加到 2013 年的每 10 万人 39 例。≥85 岁患者的增长率较高,从 2004 年的每 10 万人 400 例增加到 2013 年的每 10 万人 516 例,增加了 29%(P<.001)。在此研究期间,36.2%的患者在住院后 30 天内接受了主动脉瓣介入治疗。在接受治疗的患者中,观察到死亡率呈改善趋势,与 2004 年相比,2013 年调整后的比值比(OR)显著降低(30 天死亡率的 OR 为 0.55,1 年死亡率的 OR 为 0.74)。相比之下,未接受主动脉瓣介入治疗的患者死亡率没有明显的时间变化。
老年人的 AS 住院治疗显著增加,超出了人口增长的预期。许多 AS 患者在住院后没有接受主动脉瓣介入治疗。接受治疗的患者死亡率随着时间的推移显著改善。